ArticleOncotarget2015

Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma.

Enrico Derenzini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.